These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 36832181)

  • 1. Blood Biomarkers in Patients with Parkinson's Disease: A Review in Context of Anesthetic Care.
    Joo J; Jeong J; Park HJ
    Diagnostics (Basel); 2023 Feb; 13(4):. PubMed ID: 36832181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parkinson's disease patients have a complex phenotypic and functional Th1 bias: cross-sectional studies of CD4+ Th1/Th2/T17 and Treg in drug-naïve and drug-treated patients.
    Kustrimovic N; Comi C; Magistrelli L; Rasini E; Legnaro M; Bombelli R; Aleksic I; Blandini F; Minafra B; Riboldazzi G; Sturchio A; Mauri M; Bono G; Marino F; Cosentino M
    J Neuroinflammation; 2018 Jul; 15(1):205. PubMed ID: 30001736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulatory impairment in untreated Parkinson's disease is not restricted to Tregs: other regulatory populations are also involved.
    Álvarez-Luquín DD; Arce-Sillas A; Leyva-Hernández J; Sevilla-Reyes E; Boll MC; Montes-Moratilla E; Vivas-Almazán V; Pérez-Correa C; Rodríguez-Ortiz U; Espinoza-Cárdenas R; Fragoso G; Sciutto E; Adalid-Peralta L
    J Neuroinflammation; 2019 Nov; 16(1):212. PubMed ID: 31711508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A dysfunction of CD4+ T lymphocytes in peripheral immune system of Parkinson's disease model mice.
    Huang Y; Liu Z; Wang XQ; Qiu YH; Peng YP
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2014 Nov; 30(6):567-76. PubMed ID: 26016368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-17A exacerbates neuroinflammation and neurodegeneration by activating microglia in rodent models of Parkinson's disease.
    Liu Z; Qiu AW; Huang Y; Yang Y; Chen JN; Gu TT; Cao BB; Qiu YH; Peng YP
    Brain Behav Immun; 2019 Oct; 81():630-645. PubMed ID: 31351185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of anesthetic method on inflammatory response in patients with Parkinson's disease: a randomized controlled study.
    Hwang WJ; Joo MA; Joo J
    BMC Anesthesiol; 2020 Aug; 20(1):187. PubMed ID: 32738891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical correlation of peripheral CD4+‑cell sub‑sets, their imbalance and Parkinson's disease.
    Chen Y; Qi B; Xu W; Ma B; Li L; Chen Q; Qian W; Liu X; Qu H
    Mol Med Rep; 2015 Oct; 12(4):6105-11. PubMed ID: 26239429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine receptor D2 on CD4
    Liu Z; Zhai XR; Du ZS; Xu FF; Huang Y; Wang XQ; Qiu YH; Peng YP
    Brain Behav Immun; 2021 Nov; 98():110-121. PubMed ID: 34403737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calpain activation and progression of inflammatory cycles in Parkinson's disease.
    Gao A; McCoy HM; Zaman V; Shields DC; Banik NL; Haque A
    Front Biosci (Landmark Ed); 2022 Jan; 27(1):20. PubMed ID: 35090325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BAFF-R and TACI expression on CD3+ T cells: Interplay among BAFF, APRIL and T helper cytokines profile in systemic lupus erythematosus.
    Salazar-Camarena DC; Ortíz-Lazareno P; Marín-Rosales M; Cruz A; Muñoz-Valle F; Tapia-Llanos R; Orozco-Barocio G; Machado-Contreras R; Palafox-Sánchez CA
    Cytokine; 2019 Feb; 114():115-127. PubMed ID: 30467093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral inflammatory cytokines and motor symptoms in persons with Parkinson's disease.
    Diaz K; Kohut ML; Russell DW; Stegemöller EL
    Brain Behav Immun Health; 2022 May; 21():100442. PubMed ID: 35308082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain and Peripheral Atypical Inflammatory Mediators Potentiate Neuroinflammation and Neurodegeneration.
    Kempuraj D; Thangavel R; Selvakumar GP; Zaheer S; Ahmed ME; Raikwar SP; Zahoor H; Saeed D; Natteru PA; Iyer S; Zaheer A
    Front Cell Neurosci; 2017; 11():216. PubMed ID: 28790893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic changes in pro- and anti-inflammatory cytokines in microglia after PPAR-γ agonist neuroprotective treatment in the MPTPp mouse model of progressive Parkinson's disease.
    Pisanu A; Lecca D; Mulas G; Wardas J; Simbula G; Spiga S; Carta AR
    Neurobiol Dis; 2014 Nov; 71():280-91. PubMed ID: 25134730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarker of Neuroinflammation in Parkinson's Disease.
    Liu TW; Chen CM; Chang KH
    Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35456966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible inflammatory mechanisms and predictors of Parkinson's disease patients with fatigue (Brief Review).
    Wang H; Liu Y; Zhao J; Guo X; Hu M; Chen Y
    Clin Neurol Neurosurg; 2021 Sep; 208():106844. PubMed ID: 34388595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The imbalance between Tregs, Th17 cells and inflammatory cytokines among renal transplant recipients.
    Ma L; Zhang H; Hu K; Lv G; Fu Y; Ayana DA; Zhao P; Jiang Y
    BMC Immunol; 2015 Sep; 16():56. PubMed ID: 26400627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Liuweibuqi capsules on CD4
    Wang CY; Ding HZ; Tang X; Li ZG
    J Thorac Dis; 2018 May; 10(5):2700-2711. PubMed ID: 29997932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. α-Synuclein induces Th17 differentiation and impairs the function and stability of Tregs by promoting RORC transcription in Parkinson's disease.
    Li J; Zhao J; Chen L; Gao H; Zhang J; Wang D; Zou Y; Qin Q; Qu Y; Li J; Xiong Y; Min Z; Yan M; Mao Z; Xue Z
    Brain Behav Immun; 2023 Feb; 108():32-44. PubMed ID: 36343753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Chronic Oxidative Stress on Neuroinflammatory Response Mediated by CD4
    Solleiro-Villavicencio H; Rivas-Arancibia S
    Front Cell Neurosci; 2018; 12():114. PubMed ID: 29755324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroinflammation in Parkinson's disease: its role in neuronal death and implications for therapeutic intervention.
    Tansey MG; Goldberg MS
    Neurobiol Dis; 2010 Mar; 37(3):510-8. PubMed ID: 19913097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.